logo

For the Inventor, By the Inventor

Fort Collins, CO, United States of America

Kenneth Allen Pettine

This inventor holds 9 USPTO granted patents and 9 published patent applications. Top assignees: Direct Biologics, LLC, Other. Active years: 1993-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Allen Pettine. Retrieved from https://idiyas.com/inventor/kenneth-allen-pettine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 88.9

Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 282(Granted Patents)


Company Filing History:

goldMedal6 out of 6 
 
Direct Biologics, LLC
 patents
silverMedal3 out of 834,570 
Other
 patents

Years Active: 1993-2026

Loading Chart...
9 patents (USPTO):Explore Patents
1. 12590310 - Methods and compositions for treating inflammatory conditions associated with infectious disease (2026-03-31),
2. 12570980 - Methods and compositions for treating inflammatory conditions associated with infectious disease (2026-03-10),
3. 12569517 - Method for treating osteoarthritis with mesenchymal stem cell exosomes (2026-03-10),
4. 12502407 - Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles (2025-12-23),
5. 12453743 - Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of use (2025-10-28),
6. 12213995 - Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use (2025-02-04),
7. 9980984 - Treatment of inflammation of osteoarthritic knees with mesenchymal stem cells (2018-05-29),
8. 9408874 - Regenerative autologous bone marrow cell therapies and methods for their use in the treatment of joint pain (2016-08-09),
9. 5242448 - Bone probe (1993-09-07),

Title: Kenneth Allen Pettine: Innovator in Stem Cell Research

Introduction

Kenneth Allen Pettine is a notable inventor based in Ft. Collins, CO (US). He has made significant contributions to the field of stem cell research, holding a total of 9 patents. His work focuses on innovative treatments for various medical conditions, showcasing his dedication to advancing healthcare.

Latest Patents

Among his latest patents is a groundbreaking invention related to mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form. This patent discloses compositions and methods aimed at treating skin disorders, alleviating the effects of aging, treating wounds, orthopedic disorders, sexual dysfunction, and reducing inflammation. Another notable patent involves preparations comprising mesenchymal stem cells and cannabinoids, which outlines methods for using these compositions to treat inflammatory conditions.

Career Highlights

Kenneth has worked with various companies throughout his career, including Direct Biologics, LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.

Collaborations

Throughout his career, Kenneth has collaborated with notable individuals such as Timothy Alexander Moseley and James D Stice. These partnerships have further enriched his research and development efforts.

Conclusion

Kenneth Allen Pettine's contributions to stem cell research and innovative medical treatments highlight his role as a leading inventor in the field. His patents and collaborations reflect a commitment to improving healthcare outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…